The Strasbourg, France-headquartered European Science Foundation has launched EuroBioFund, a new inititative that aims "to promote and coordinate interaction among European life sciences researchers and funders."
The ESF announcement notes that, "the life sciences encompass research fields that have a direct impact on the quality of our health, food and environment including pharmaceuticals, genetics, systems biology and biotechnology."
In what the Foundation refers to as the "post-genomic era," a revolution in terms of life science research approaches is underway, leading to new infrastructure needs and technology developments that will transform people's lives, the ESF says.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze